Several biomarkers may predict improved treatment responses and outcomes in patients with triple-negative breast cancer. Several biomarkers, including the T-cell inflamed 18-gene expression profile, ...

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ: SGEN) today announced updated data from an ongoing phase 1 clinical trial evaluating ladiratuzumab vedotin in patients with metastatic ...

Blood is made up of red blood cells, white blood cells, platelets, and plasma. Markers called antigens are found on the surface of red blood cells, and differences in these markers classify various ...

Race does not significantly impact tumor mutations of triple-negative breast cancer, suggesting genetics and environmental ...